2-[carboxymethyl(ethyl)amino]-6-[[2-(2,5-dioxopyrrol-1-yl)acetyl]amino]hexanoic acid
C16H23N3O7 — CID 122418743
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[carboxymethyl(ethyl)amino]-6-[[2-(2,5-dioxopyrrol-1-yl)acetyl]amino]hexanoic acid
2-[carboxymethyl(ethyl)amino]-6-[[2-(2,5-dioxopyrrol-1-yl)acetyl]amino]hexanoic acid (PubChem CID 122418743) has the molecular formula C16H23N3O7 and a molecular weight of 369.37 g/mol. Its IUPAC name is 2-[carboxymethyl(ethyl)amino]-6-[[2-(2,5-dioxopyrrol-1-yl)acetyl]amino]hexanoic acid.
Molecular Properties
| Compound Name | 2-[carboxymethyl(ethyl)amino]-6-[[2-(2,5-dioxopyrrol-1-yl)acetyl]amino]hexanoic acid |
|---|---|
| PubChem CID | 122418743 |
| Molecular Formula | C16H23N3O7 |
| Molecular Weight | 369.37 g/mol |
| Exact Mass | 369.15 |
| IUPAC Name | 2-[carboxymethyl(ethyl)amino]-6-[[2-(2,5-dioxopyrrol-1-yl)acetyl]amino]hexanoic acid |
| SMILES | CCN(CC(=O)O)C(CCCCNC(=O)CN1C(=O)C=CC1=O)C(=O)O |
| InChI | InChI=1S/C16H23N3O7/c1-2-18(10-15(23)24)11(16(25)26)5-3-4-8-17-12(20)9-19-13(21)6-7-14(19)22/h6-7,11H,2-5,8-10H2,1H3,(H,17,20)(H,23,24)(H,25,26) |
| InChIKey | VNVUZQKIQDSHBD-UHFFFAOYSA-N |
| XLogP | -0.94 |
| TPSA | 144.32 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 369.37 |
| LogP ≤ 5 | -0.94 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122418743 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.